Press Statement Woodcock s Role in Aducanumab s Approval Must Be Investigated As Part of IG Probe HRG Publication 2593 Public Citizen welcomes Food and Drug Administration FDA Commissioner Janet Woodcock s belated request for an independent Inspector General IG investigation of her agency s inappropriately close collaboration with Biogen regarding the Alzheimer s disease drug aducanumab, as we had urged her to do nearly six months ago <a href=https://enhanceyourlife.mom/>dapoxetine for premature</a> According to the CDC, some people who receive the vaccine could experience a fever, particularly after their second dose
